(HealthDay)—The type 2 diabetes prescription drug canagliflozin (brand names Invokana, Invokamet, Invokamet XR) appears to increase the risk of leg and foot amputations, the U.S. Food and Drug Administration says.
May 17, 2017
0
0
Cinnamon may lessen the risk of cardiovascular damage of a high-fat diet by activating the body's antioxidant and anti-inflammatory systems and slowing the fat-storing process, according to a preliminary animal study presented ...
May 6, 2017
0
7
Simple calf muscle stretching may reduce leg pain when walking and increase blood flow for people living with peripheral artery disease, according to a preliminary abstract presented at the American Heart Association's Arteriosclerosis, ...
May 5, 2017
0
3
Resveratrol, a natural compound found in red wine, peanuts, berries and the skin of red grapes, may reduce artery stiffness in some people with Type 2 diabetes, according to an abstract presented at the American Heart Association's ...
May 4, 2017
0
0
Aspirin use may not provide cardiovascular benefits for patients who have peripheral vascular disease, an analysis by University of Florida Health researchers has found.
Apr 12, 2017
0
0
Among adults who entered a study more than 25 years ago, an increasing number of midlife vascular risk factors, such as obesity, high blood pressure, diabetes, high cholesterol and smoking, were associated with elevated levels ...
Apr 11, 2017
0
0
Autoimmune disease may be linked to a heightened risk of dementia, indicates a large long term study, published in the Journal of Epidemiology & Community Health.
Mar 1, 2017
0
20
(HealthDay)—Heart disease affects more than just the heart. It also can take a toll on the legs, feet, kidneys and even the brain, according to vascular surgery experts.
Feb 14, 2017
0
0
Acetylcholine is a neurotransmitter in the brain that plays an important role in controlling attention and cognition. Acetylcholine system dysfunction is believed to be one of the causes of Alzheimer's disease (AD) and vascular ...
Jan 26, 2017
0
0
Investigators at the University of Alabama at Birmingham have presented the first case study of a patient experiencing a hemorrhagic stroke—a brain bleed—following consumption of an energy drink.
Nov 28, 2016
1
19
